Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
Authors
Posts by Giuliana Miglierini
Giuliana Miglierini
161 POSTS
0 COMMENTS
Human and veterinary medicines: EMA’s highlights of 2020
Giuliana Miglierini
-
23 February 2021
0
The socio-economic impact of IMI1 projects
Giuliana Miglierini
-
23 February 2021
0
ICH’s reflection paper and consultation on patient focused drug development
Giuliana Miglierini
-
23 February 2021
0
A report on the impact of biosimilar competition in Europe
Giuliana Miglierini
-
22 February 2021
0
Post-Brexit era
Giuliana Miglierini
-
26 January 2021
0
EMA and HMA’s new joint regulatory strategy
Giuliana Miglierini
-
26 January 2021
0
Trends in APIs development for 2021
Giuliana Miglierini
-
26 January 2021
0
Time for change: The digital transformation of the Pharmaceutical Industry
Giuliana Miglierini
-
26 January 2021
0
Real-time control of the access to cleanrooms
Giuliana Miglierini
-
25 January 2021
0
Hungary: Logistic challenges in the pharma industry due to Covid-19
Giuliana Miglierini
-
18 December 2020
0
1
2
3
...
17
Page 1 of 17
